1. Optimizing antiemetic treatment for chemotherapy-induced nausea and vomiting in Japan: Update summary of the 2015  Japan Society of Clinical Oncology Clinical Practice Guidelines for Antiemesis

   • Kenjiro Aogi
   • Hideki Takeuchi
   • Kouichi Hirata

   Special Article Open access 08 November 2020 Pages: 1 - 17

   

2. Photodynamic diagnosis and therapy for urothelial carcinoma and prostate cancer: new imaging technology and therapy

   • Hideo Fukuhara
   • Shinkuro Yamamoto
   • Keiji Inoue

   Invited Review Article 26 May 2020 Pages: 18 - 25

   

3. Key transporters leading to specific protoporphyrin IX accumulation in cancer cell following administration of aminolevulinic acid in photodynamic therapy/diagnosis

   • Hung Wei Lai
   • Taku Nakayama
   • Shun-ichiro Ogura

   Invited Review Article 01 September 2020 Pages: 26 - 33

   

4. Acid-suppressive agents and survival outcomes in patients with cancer: a systematic review and meta-analysis

   • Hyun Jin Song
   • Kiyon Rhew
   • In-Hyuk Ha

   Original Article 22 October 2020 Pages: 34 - 50

   

5. Phase II trial of combination treatment with S-1/cetuximab in patients with platinum-ineligible recurrent and/or metastatic squamous cell carcinoma of the head and neck

   • Jun Taguchi
   • Yasushi Shimizu
   • Hirotoshi Dosaka-Akita

   Original Article 29 September 2020 Pages: 51 - 58

   

6. The incidence of newly diagnosed secondary cancer; sub-analysis the prospective study of the second-look procedure for transoral surgery in patients with T1 and T2 head and neck cancer

   • Goshi Nishimura
   • Daisuke Sano
   • Nobuhiko Oridate

   Original Article 14 September 2020 Pages: 59 - 65

   

7. The prognostic role of prognostic nutritional index in nasopharyngeal carcinoma: A systematic review and meta-analysis

   • Min Tang
   • Zhongxiong Jia
   • Ju Zhang

   Original Article 07 October 2020 Pages: 66 - 77

   

8. Clinical outcomes and predictive value of programmed cell death-ligand 1 expression in response to anti-programmed cell death 1/ligand 1 antibodies in non-small cell lung cancer patients with performance status 2 or greater

   • Takayuki Jodai
   • Koichi Saruwatari
   • Takuro Sakagami

   Original Article 23 September 2020 Pages: 78 - 86

   

9. Prognostic impact of preoperative FDG-PET positive lymph nodes in lung cancer

   • Hideki Endoh
   • Akihiro Ichikawa
   • Noboru Oriuchi

   Original Article 19 September 2020 Pages: 87 - 94

   

10. Clinicopathological features of radiological early malignant pleural mesothelioma with no apparent tumor or pleural thickening

    • Akifumi Nakamura
    • Masaki Hashimoto
    • Seiki Hasegawa

    Original Article 10 September 2020 Pages: 95 - 103

    

11. Opioid-induced constipation in patients with cancer pain in Japan (OIC-J study): a post hoc subgroup analysis of patients with gastrointestinal cancer

    • Toshiyuki Harada
    • Hisao Imai
    • Akihiro Tokoro

    Original Article Open access 17 October 2020 Pages: 104 - 110

    

12. Combination of TAS-102 and bevacizumab as third-line treatment for metastatic colorectal cancer: TAS-CC3 study

    • Yoichiro Yoshida
    • Takeshi Yamada
    • On behalf of the TAS CC3 Study Group.

    Original Article 21 October 2020 Pages: 111 - 117

    

13. Predisposing factors and clinical impact of high-output syndrome after sphincter-preserving surgery with covering ileostomy for rectal cancer: a retrospective single-center cohort study

    • Ryota Nakanishi
    • Tsuyoshi Konishi
    • Yosuke Fukunaga

    Original Article 09 September 2020 Pages: 118 - 125

14. The survival benefit of neoadjuvant chemotherapy for resectable colorectal liver metastases with high tumor burden score

    • Yoshihiko Yonekawa
    • Kay Uehara
    • Masato Nagino

    Original Article 19 October 2020 Pages: 126 - 134

    

15. Prognostic value of preoperative glucose to lymphocyte ratio in patients with resected pancreatic cancer

    • Yueming Zhang
    • Yaolin Xu
    • Wenhui Lou

    Original Article 21 September 2020 Pages: 135 - 144

    

16. A novel nomogram for predicting local recurrence-free survival after surgical resection for retroperitoneal liposarcoma from a Chinese tertiary cancer center

    • Guoqiang Xue
    • Zhen Wang
    • Chunyi Hao

    Original Article 17 October 2020 Pages: 145 - 153

    

17. Comparison of nivolumab plus ipilimumab with tyrosine kinase inhibitors as first-line therapies for metastatic renal-cell carcinoma: a multicenter retrospective study

    • Koichi Kido
    • Shingo Hatakeyama
    • Chikara Ohyama

    Original Article 16 October 2020 Pages: 154 - 162

    

18. Efficacy and safety of low-dose everolimus treatment for renal angiomyolipoma associated with tuberous sclerosis complex

    • Takashi Hatano
    • Katsuhisa Endo
    • Mayumi Tamari

    Original Article 29 September 2020 Pages: 163 - 168

    

19. Prognostic value of pre-treatment risk stratification and post-treatment neutrophil/lymphocyte ratio change for pembrolizumab in patients with advanced urothelial carcinoma

    • Yoshiaki Yamamoto
    • Junji Yatsuda
    • Hideyasu Matsuyama

    Original Article 18 September 2020 Pages: 169 - 177

    

20. UroVysion^® predicts intravesical recurrence after radical nephroureterectomy for urothelial carcinoma of the upper urinary tract: a prospective study

    • Hidehiro Iwata
    • Naoto Sassa
    • Toyonori Tsuzuki

    Original Article 21 September 2020 Pages: 178 - 185

    

21. Determination of risk factors for progression in patients with viable tumor at post-chemotherapy lymph node dissection due to disseminated non-seminomatous germ-cell tumors

    • Mesut Altan
    • Hakan Bahadır Haberal
    • Haluk Özen

    Original Article 22 September 2020 Pages: 186 - 191

22. Clinical indicators for predicting prognosis after radium-223 administration in castration-resistant prostate cancer with bone metastases

    • Yoshiyuki Yamamoto
    • Yohei Okuda
    • Kazuo Nishimura

    Original Article 01 September 2020 Pages: 192 - 198

    

23. Association between the baseline frailty and quality of life in patients with prostate cancer (FRAQ-PC study)

    • Tomoko Hamaya
    • Shingo Hatakeyama
    • Chikara Ohyama

    Original Article 16 October 2020 Pages: 199 - 206

    

24. Phase II study of a new multidisciplinary therapy using once every 3 week carboplatin plus dose-dense weekly paclitaxel before and after radical hysterectomy for locally advanced cervical cancer

    • Shoji Nagao
    • Kasumi Yamamoto
    • Junzo Kigawa

    Original Article 22 September 2020 Pages: 207 - 215

    

25. Evaluation of adjuvant chemotherapy after abdominal trachelectomy for cervical cancer: a single-institution experience

    • Kaoru Okugawa
    • Hideaki Yahata
    • Kiyoko Kato

    Original Article 03 September 2020 Pages: 216 - 224

    

26. The prognostic significance of whole-body and spleen MTV (metabolic tumor volume) scanning for patients with diffuse large B cell lymphoma

    • Shintaro Yamanaka
    • Masao Miyagawa
    • Yoshihiro Yakushijin

    Original Article 23 October 2020 Pages: 225 - 232